Universitat de Lleida
    • English
    • català
    • español
  • English 
    • English
    • català
    • español
  • Login
Repositori Obert UdL
View Item 
  •   Home
  • Recerca
  • Medicina
  • Articles publicats (Medicina)
  • View Item
  •   Home
  • Recerca
  • Medicina
  • Articles publicats (Medicina)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Fluorescence in situ hybridization (FISH) of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes

Thumbnail
View/Open
022759.pdf (923.9Kb)
Issue date
2015-05-01
Author
Sánchez Castro, Judit
Marco Betés, Victor
Gómez Arbonés, Javier
García Cerecedo, Tomás
López Ortega, Ricard
Talavera, Elisabeth
Fernández-Ruiz, Sara
Ademà, Vera
Marugan, Isabel
Luño, Elisa
Sanzo, Carmen
Vallespí, Teresa
Arenillas, Leonor
Marco Buades, Josefa
Batlle, Ana
Buño, Ismael
Martín Ramos, María Luisa
Blázquez Rios, Beatriz
Collado Nieto, Rosa
Vargas, María Teresa
González Martínez, Teresa
Sanz, Guillermo
Solé, Francesc
Suggested citation
Sánchez Castro, Judit; Marco Betés, Victor; Gómez Arbonés, Javier; García Cerecedo, Tomás; López Ortega, Ricard; Talavera, Elisabeth; ... Solé, Francesc. (2015) . Fluorescence in situ hybridization (FISH) of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes. Leukemia & Lymphoma, 2015. https://doi.org/10.3109/10428194.2015.1028053.
Impact


Web of Science logo    citations in Web of Science

Scopus logo    citations in Scopus

Google Scholar logo  Google Scholar
Share
Export to Mendeley
Metadata
Show full item record
Abstract
Conventional G-banding cytogenetics (CC) detects chromosome 17 (chr17) abnormalities in 2% of patients with de novo myelodysplastic syndromes (MDS). We used CC and fluorescence in situ hybridization (FISH) (LSI p53/17p13.1) to assess deletion of 17p in 531 patients with de novo MDS from the Spanish Group of Hematological Cytogenetics. FISH detected<br>17 or 17p abnormalities in 13 cases (2.6%) in whom no 17p abnormalities were revealed by CC: 9% of patients with a normal karyotype, 0% in non-informative cytogenetics, 50% of patients with a chr17 abnormality without loss of 17p and in 4.7% of cases with an abnormal karyotype not involving chr17. Our results suggest that applying FISH of 17p13 to identify the number of copies of the TP53 gene could be beneficial in patients with a complex karyotype. We recommend using FISH of 17p13 in young patients with a normal karyotype or non-informative cytogenetics, and always in isolated del(17p)
URI
http://hdl.handle.net/10459.1/48614
DOI
https://doi.org/10.3109/10428194.2015.1028053
Is part of
Leukemia & Lymphoma, 2015
European research projects
Collections
  • Articles publicats (Medicina) [456]

Contact Us | Send Feedback | Legal Notice
© 2022 BiD. Universitat de Lleida
Metadata subjected to 
 

 

Browse

All of the repositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

Statistics

View Usage Statistics

D'interès

Política institucional d'accés obertDiposita les teves publicacionsDiposita dades de recercaSuport a la recerca

Contact Us | Send Feedback | Legal Notice
© 2022 BiD. Universitat de Lleida
Metadata subjected to